Navigation Links
Glaxo Official Memo Urged Scientists to Withhold Information About Paxil's Risks, Trial Hears; Pharmaceutical Industry Today Offers Complete News Coverage
Date:9/16/2009

WASHINGTON, Sept. 16 /PRNewswire-USNewswire/ -- Antidepressant drug Paxil, which generated about 2.1% of GlaxoSmithKline's total revenue last year, has been known to cause birth defects, but the world's second-biggest drugmaker hid its risks to pump up profits, a Philadelphia court has heard.

According to available information, Glaxo failed to properly test the drug and urged scientists to conceal Paxil's risks. The Philadelphia trial is the first of more than 600 cases against the London-based company.

Are you satisfied with the way your regular news sources report on these important stories? If not, try Pharmaceutical Industry Today (http://pharmaceuticals.einnews.com/), for free, to see what you may have been missing.

See:

-- GlaxoSmithKline News - http://pharmaceuticals.einnews.com/news/glaxosmithkline

-- Paxil News - http://pharmaceuticals.einnews.com/news/paxil

-- Latest Pharmaceutical News - http://pharmaceuticals.einnews.com/

For a free trial to Pharmaceutical Industry Today, go to: http://pharmaceuticals.einnews.com/users/register.php

About the publisher of Pharmaceutical Industry Today, EIN News, http://www.einnews.com/

EIN News was established in 1995, and through the years has built more than 200,000 news feeds organized within over 80 individual news sites. The company has launched the well-known 'Russia News Service' brand and opened Internet news access to China with 'Inside China Today'.

Offering a unique combination of human editing and proprietary scanning software, EIN News won Europe's coveted Momentum Award as the most innovative internet company on the continent. Serving millions of customers, the company distributes its feeds via email or mobile news alerts, online and other channels such as Newsfeed Maker (http://www.newsfeedmaker.com/) and EIN Presswire (http://www.einpresswire.com/).


'/>"/>
SOURCE EIN News
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. By 2018, GlaxoSmithKlines Votrient Will Garner Sales of $640 Million and Will Overtake Pfizers Sutent as the Renal Cell Carcinoma Market Leader
2. GlaxoSmithKline Statement Confirming alli Safety
3. Mahindra Satyam Signs 5 Year SAP Contract with GlaxoSmithKline
4. GlaxoSmithKline 13th Annual IMPACT Awards Seek Nonprofits Providing Access to Healthcare
5. GlaxoSmithKline Opens $600million Vaccine Plant In Singapore
6. GlaxoSmithKline Consumer Healthcare Makes Agency Changes to Support Growth on Global Brands
7. GlaxoSmithKline Travel Health: 55 percent of travellers needlessly put themselves at risk from a potentially fatal virus
8. Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009
9. GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million
10. GlaxoSmithKline Update: Influenza A (H1N1)
11. GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Finally, a bruise cream that really ... cream can be incorporated into the post-surgical treatment plans of a variety of other ... dermaka cream is very effective for bruising and causes a rapid resolution of bruising ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Seema Daulat, a native Texan and University ... Lamar location as of July 13, 2016. , Dr. Daulat earned her Doctorate of ... she regularly volunteered at the Agape Clinic serving Dallas’ underprivileged community. , Following medical ...
(Date:6/23/2016)... ... 23, 2016 , ... SyncDog, Inc. , the leading ... is featured in the current issue of Silicon Review magazine. Silicon ... technology solutions and features them in their magazine. The magazine allows top-level executives ...
(Date:6/23/2016)... ... 23, 2016 , ... The U.S. Supreme Court decision on immigration has significant ... The Senior Citizens League (TSCL) . “President Obama’s executive actions on immigration would ... who worked in this country illegally, even though the newly - issued green cards ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
Breaking Medicine Technology: